GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LENZ Therapeutics Inc (NAS:LENZ) » Definitions » Market Cap

LENZ Therapeutics (LENZ Therapeutics) Market Cap : $473.41 Mil (As of Jun. 16, 2024)


View and export this data going back to 2024. Start your Free Trial

What is LENZ Therapeutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). LENZ Therapeutics's share price for the quarter that ended in Mar. 2024 was $22.33. LENZ Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 25.50 Mil. Therefore, LENZ Therapeutics's market cap for the quarter that ended in Mar. 2024 was $569.42 Mil.

LENZ Therapeutics's quarterly market cap stayed the same from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.00 Mil) but then increased from Dec. 2023 ($0.00 Mil) to Mar. 2024 ($569.42 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. LENZ Therapeutics's Enterprise Value for Today is $260.72 Mil.

LENZ Therapeutics Market Cap Historical Data

The historical data trend for LENZ Therapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LENZ Therapeutics Market Cap Chart

LENZ Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Market Cap
- - -

LENZ Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial - - - - 569.42

Competitive Comparison of LENZ Therapeutics's Market Cap

For the Biotechnology subindustry, LENZ Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LENZ Therapeutics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LENZ Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where LENZ Therapeutics's Market Cap falls into.


LENZ Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

LENZ Therapeutics's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=$0*25.5335
=$0.00

LENZ Therapeutics's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=$22.33*25.5001
=$569.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LENZ Therapeutics  (NAS:LENZ) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

LENZ Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of LENZ Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

LENZ Therapeutics (LENZ Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LENZ Therapeutics Inc (NAS:LENZ) » Definitions » Market Cap
Comparable Companies
Traded in Other Exchanges
N/A
Address
445 Marine View Avenue, STE #320, Del Mar, CA, USA, 92014
Website
https://www.lenz-tx.com
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

LENZ Therapeutics (LENZ Therapeutics) Headlines

From GuruFocus

LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress

By Business Wire • 03-21-2024